Latest Commercialisation News

Orthocell Limited has posted record revenue for FY2026, driven by strong sales growth of Remplir™ and Striate+™ products in Australia, the US, and new international markets, supported by a robust $44.1 million cash position.

OncoSil Medical has completed key manufacturing validation cycles with Cyclotek, paving the way for scalable Australian production of its OncoSil™ device. With a $2.1 million capital investment, the company aims to boost margins and supply chain control ahead of commercial launch in late 2026.

PMET Resources has achieved over 97% caesium extraction from pollucite concentrate using sulphuric acid leaching at SGS Canada, while parallel proprietary testwork with Koch Technology Solutions advances value-added caesium chemical pathways.

Patrys has assigned its deoxymab intellectual property to Yale University in a deal granting it half of all future commercialisation revenue, reducing capital needs while keeping long-term upside.

Prairie Lithium has taken a major step toward commercial lithium production with the arrival of North America’s largest Direct Lithium Extraction unit at its Saskatchewan project, underpinning its Phase 1 launch and revenue path.

Rimfire Pacific Mining has engaged UK-based Xcelsior Capital Advisors to support funding, government relations, and marketing for its NSW scandium projects, leveraging Xcelsior’s ties to the Wogen group and global critical minerals networks.

Archer Materials made significant strides in quantum chip fabrication and quantum neural network fraud detection, while progressing its Biochip beta prototype. A $7 million placement post-quarter strengthens its financial position to accelerate development and commercialisation.

ReNerve has locked in a flexible A$5 million convertible note facility with RiverFort, drawing an initial A$1.6 million to back its commercial push and US sales ramp-up.

Proteomics International has won a key US patent for its PromarkerEndo blood test, bolstering its commercial foothold in the world’s largest healthcare market. The patented technology offers a non-invasive, accurate diagnosis of endometriosis, a condition that currently takes years to detect.

Australian Rare Earths (ASX: AR3) has discovered a promising niobium-rare earth carbonatite system at its Overland Project, marked by significant mineralisation in a single drill hole and linked to a large magnetic anomaly.

EV Resources (ASX:EVR) accelerates its Tecomatlán plant timeline to 10-12 months for flotation circuit operation using third-party ore, while concluding Phase 1 drilling at Los Lirios with high-grade antimony results and validated assays.

Temas Resources has filed a new patent for its proprietary Regenerative Chloride Leach (RCL) process targeting vanadium extraction, broadening its critical minerals technology portfolio and reinforcing its commercial licensing ambitions.